Turning Point Therapeutics Inc. (TPTX) NASDAQ
$76.01 - (-)
Market Cap: -
As of 08/16/22 12:00 AM EDT. Market closed.
Turning Point Therapeutics Inc. (TPTX)
NASDAQ
$76.01
- (-)
Market Cap: -
As of 08/16/22 12:00 AM EDT. Market closed.
Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. ... read more
Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. Repotrectinib, which is being studied in a registrational Phase 2 study in adults and a Phase 1/2 study in pediatric patients, has shown antitumor activity and durable responses among kinase inhibitor treatment-naïve and pre-treated patients. The company's pipeline of drug candidates also includes TPX-0022, targeting MET, CSF1R and SRC, which is being studied in a Phase 1 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in MET; TPX-0046, targeting RET, which is being studied in a Phase 1/2 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in RET; and TPX-0131, a next-generation ALK inhibitor currently pending IND submission. Turning Point's next-generation kinase inhibitors are designed to bind to their targets with greater precision and affinity than existing therapies, with a novel, compact structure that has demonstrated an ability to potentially overcome treatment resistance common with other kinase inhibitors. The company is driven to develop therapies that mark a turning point for patients in their cancer treatment. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
George Simeon | Director | Aug 17, 2022 | Option Exercise | $76.00 | 2,253,660 | 171,278,160 | 0 | Aug 17, 2022, 04:40 PM |
Alles Mark J | Director | Aug 17, 2022 | Option Exercise | $76.00 | 2,000 | 152,000 | 0 | Aug 17, 2022, 04:32 PM |
TOMBESI PAOLO | EVP & Chief Financial Officer | Aug 17, 2022 | Option Exercise | $76.00 | 29,778 | 2,263,128 | 0 | Aug 17, 2022, 04:31 PM |
Hirmand Mohammad | EVP and Chief Medical Officer | Aug 17, 2022 | Option Exercise | $76.00 | 41,284 | 3,137,584 | 0 | Aug 17, 2022, 04:26 PM |
Countouriotis Athena | President & CEO | Aug 17, 2022 | Option Exercise | $76.00 | 110,959 | 8,432,884 | 0 | Aug 17, 2022, 04:23 PM |
TOMBESI PAOLO | EVP & Chief Financial Officer | Jul 27, 2022 | Sale | $74.94 | 1,183 | 88,654 | 28,700 | Jul 29, 2022, 04:18 PM |
Reich Siegfried | EVP & Chief Scientific Officer | Feb 09, 2022 | Sale | $36.30 | 397 | 14,411 | 3,448 | Feb 11, 2022, 06:10 PM |
Partridge Andrew John | EVP & Chief Commercial Officer | Feb 09, 2022 | Sale | $36.30 | 221 | 8,022 | 22,078 | Feb 11, 2022, 06:09 PM |
North Annette | EVP & General Counsel | Feb 09, 2022 | Sale | $36.30 | 669 | 24,285 | 11,696 | Feb 11, 2022, 06:09 PM |
Hirmand Mohammad | EVP & Chief Medical Officer | Feb 09, 2022 | Sale | $36.30 | 669 | 24,285 | 6,838 | Feb 11, 2022, 06:08 PM |
Countouriotis Athena | President & CEO | Feb 09, 2022 | Sale | $36.30 | 2,971 | 107,847 | 47,930 | Feb 11, 2022, 06:07 PM |
North Annette | EVP, General Counsel & Secty. | Aug 30, 2021 | Option Exercise | $17.00 | 10,000 | 170,000 | 22,365 | Aug 31, 2021, 05:26 PM |
North Annette | EVP, General Counsel & Secty. | Aug 30, 2021 | Sale | $80.00 | 10,000 | 800,000 | 12,365 | Aug 31, 2021, 05:26 PM |
Partridge Andrew John | EVP & Chief Commercial Officer | Jul 14, 2021 | Sale | $74.90 | 1,869 | 139,988 | 21,767 | Jul 15, 2021, 05:53 PM |
Alles Mark J | Director | Jun 21, 2021 | Buy | $81.34 | 2,000 | 162,680 | 2,000 | Jun 21, 2021, 09:14 PM |
Baker Brian Lee | SVP of Finance and Admin. | Mar 23, 2021 | Option Exercise | $4.67 | 28,435 | 132,906 | 32,551 | Mar 24, 2021, 09:54 PM |
Baker Brian Lee | SVP of Finance and Admin. | Mar 23, 2021 | Sale | $100.65 | 28,435 | 2,862,082 | 27,632 | Mar 24, 2021, 09:54 PM |
North Annette | EVP, General Counsel & Secty. | Mar 08, 2021 | Option Exercise | $17.00 | 20,000 | 340,000 | 26,483 | Mar 09, 2021, 07:26 PM |
North Annette | EVP, General Counsel & Secty. | Mar 08, 2021 | Sale | $109.80 | 20,000 | 2,195,939 | 25,983 | Mar 09, 2021, 07:26 PM |
Reich Siegfried | EVP & Chief Scientific Officer | Mar 04, 2021 | Option Exercise | $51.28 | 35,550 | 1,823,004 | 39,395 | Mar 05, 2021, 08:56 PM |
Reich Siegfried | EVP & Chief Scientific Officer | Mar 04, 2021 | Sale | $105.04 | 35,550 | 3,734,075 | 36,390 | Mar 05, 2021, 08:56 PM |
Countouriotis Athena | President & CEO | Feb 11, 2021 | Option Exercise | $3.20 | 8,942 | 28,614 | 59,137 | Feb 11, 2021, 08:28 PM |
Countouriotis Athena | President & CEO | Feb 10, 2021 | Option Exercise | $3.20 | 25,392 | 81,254 | 75,587 | Feb 11, 2021, 08:28 PM |
Countouriotis Athena | President & CEO | Feb 09, 2021 | Option Exercise | $3.20 | 25,666 | 82,131 | 75,861 | Feb 11, 2021, 08:28 PM |
Countouriotis Athena | President & CEO | Feb 11, 2021 | Sale | $137.38 | 8,942 | 1,228,446 | 54,818 | Feb 11, 2021, 08:28 PM |
Countouriotis Athena | President & CEO | Feb 10, 2021 | Sale | $136.31 | 25,392 | 3,461,116 | 74,562 | Feb 11, 2021, 08:28 PM |
Countouriotis Athena | President & CEO | Feb 09, 2021 | Sale | $138.68 | 25,666 | 3,559,475 | 69,661 | Feb 11, 2021, 08:28 PM |
North Annette | EVP, General Counsel & Secty. | Feb 02, 2021 | Option Exercise | $17.00 | 9,016 | 153,272 | 9,016 | Feb 02, 2021, 09:50 PM |
North Annette | EVP, General Counsel & Secty. | Feb 01, 2021 | Option Exercise | $17.00 | 15,984 | 271,728 | 15,984 | Feb 02, 2021, 09:50 PM |
North Annette | EVP, General Counsel & Secty. | Feb 02, 2021 | Sale | $129.88 | 9,016 | 1,170,989 | 8,616 | Feb 02, 2021, 09:50 PM |
North Annette | EVP, General Counsel & Secty. | Feb 01, 2021 | Sale | $123.65 | 15,984 | 1,976,374 | 14,354 | Feb 02, 2021, 09:50 PM |
Larson Yi | EVP & Chief Financial Officer | Feb 01, 2021 | Option Exercise | $54.03 | 15,702 | 848,379 | 18,406 | Feb 02, 2021, 09:47 PM |
Larson Yi | EVP & Chief Financial Officer | Feb 02, 2021 | Option Exercise | $54.03 | 14,298 | 772,521 | 17,002 | Feb 02, 2021, 09:47 PM |
Larson Yi | EVP & Chief Financial Officer | Feb 01, 2021 | Sale | $123.62 | 15,702 | 1,941,105 | 13,623 | Feb 02, 2021, 09:47 PM |
Larson Yi | EVP & Chief Financial Officer | Feb 02, 2021 | Sale | $130.14 | 14,298 | 1,860,813 | 16,002 | Feb 02, 2021, 09:47 PM |
Baker Brian Lee | SVP of Finance and Admin. | Jan 07, 2021 | Option Exercise | $4.67 | 28,438 | 132,918 | 32,246 | Jan 08, 2021, 09:08 PM |
Baker Brian Lee | SVP of Finance and Admin. | Jan 07, 2021 | Sale | $122.26 | 31,238 | 3,819,090 | 29,446 | Jan 08, 2021, 09:08 PM |
Hirmand Mohammad | EVP and Chief Medical Officer | Jan 04, 2021 | Option Exercise | $54.73 | 8,747 | 478,723 | 9,331 | Jan 05, 2021, 09:03 PM |
Hirmand Mohammad | EVP and Chief Medical Officer | Jan 05, 2021 | Option Exercise | $54.73 | 1,253 | 68,577 | 1,537 | Jan 05, 2021, 09:03 PM |
Hirmand Mohammad | EVP and Chief Medical Officer | Jan 05, 2021 | Sale | $120.00 | 1,253 | 150,360 | 284 | Jan 05, 2021, 09:03 PM |
Hirmand Mohammad | EVP and Chief Medical Officer | Jan 04, 2021 | Sale | $120.49 | 9,047 | 1,090,046 | 9,031 | Jan 05, 2021, 09:03 PM |
Cui Jingrong Jean | Director | Jun 09, 2020 | Sale | $65.81 | 9,500 | 625,194 | 549,471 | Jun 10, 2020, 05:26 PM |
Cui Jingrong Jean | Director | Jun 08, 2020 | Sale | $63.45 | 18,500 | 1,173,888 | 566,511 | Jun 08, 2020, 08:26 PM |
Cui Jingrong Jean | Director | Jun 05, 2020 | Sale | $64.21 | 18,500 | 1,187,868 | 583,281 | Jun 08, 2020, 08:26 PM |
Cui Jingrong Jean | Director | Jun 04, 2020 | Sale | $64.80 | 18,500 | 1,198,891 | 603,483 | Jun 08, 2020, 08:26 PM |
George Simeon | Director | May 21, 2020 | Buy | $60.00 | 83,333 | 4,999,980 | 2,253,660 | May 26, 2020, 05:57 PM |
Countouriotis Athena | President & CEO | May 21, 2020 | Buy | $60.00 | 4,166 | 249,960 | 26,872 | May 26, 2020, 05:55 PM |
GLAXOSMITHKLINE PLC | Director | May 21, 2020 | Buy | $60.00 | 83,333 | 4,999,980 | 2,253,660 | May 26, 2020, 04:17 PM |
Cui Jingrong Jean | Director | May 19, 2020 | Sale | $57.73 | 7,000 | 404,108 | 625,183 | May 21, 2020, 07:05 PM |
Cui Jingrong Jean | Director | May 21, 2020 | Sale | $59.65 | 7,000 | 417,550 | 605,483 | May 21, 2020, 07:05 PM |
Cui Jingrong Jean | Director | May 20, 2020 | Sale | $60.15 | 7,000 | 421,045 | 618,883 | May 21, 2020, 07:05 PM |
Cui Jingrong Jean | Director | May 08, 2020 | Sale | $53.86 | 11,500 | 619,351 | 637,153 | May 12, 2020, 08:09 PM |
Cui Jingrong Jean | Director | May 07, 2020 | Sale | $52.86 | 18,500 | 977,886 | 651,077 | May 07, 2020, 06:52 PM |
Cui Jingrong Jean | Director | May 06, 2020 | Sale | $52.94 | 18,500 | 979,323 | 668,811 | May 07, 2020, 06:52 PM |
Cui Jingrong Jean | Director | May 05, 2020 | Sale | $54.02 | 18,500 | 999,426 | 689,385 | May 07, 2020, 06:52 PM |
Cui Jingrong Jean | Director | Apr 23, 2020 | Sale | $51.92 | 7,000 | 363,408 | 704,183 | Apr 24, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Apr 22, 2020 | Sale | $51.78 | 7,000 | 362,481 | 708,683 | Apr 24, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Apr 24, 2020 | Sale | $51.01 | 7,000 | 357,090 | 697,170 | Apr 24, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Apr 13, 2020 | Sale | $50.05 | 708 | 35,438 | 714,891 | Apr 13, 2020, 07:16 PM |
Cui Jingrong Jean | Director | Apr 09, 2020 | Sale | $47.45 | 11,500 | 545,648 | 720,609 | Apr 13, 2020, 07:16 PM |
Cui Jingrong Jean | Director | Apr 06, 2020 | Sale | $43.51 | 18,500 | 804,874 | 780,991 | Apr 08, 2020, 07:21 PM |
Cui Jingrong Jean | Director | Apr 08, 2020 | Sale | $46.25 | 18,500 | 855,604 | 738,797 | Apr 08, 2020, 07:21 PM |
Cui Jingrong Jean | Director | Apr 07, 2020 | Sale | $44.86 | 18,500 | 829,998 | 759,091 | Apr 08, 2020, 07:21 PM |
Cui Jingrong Jean | Director | Mar 26, 2020 | Sale | $46.03 | 11,500 | 529,372 | 786,991 | Mar 27, 2020, 06:27 PM |
Cui Jingrong Jean | Director | Mar 25, 2020 | Sale | $45.42 | 17,792 | 808,090 | 809,283 | Mar 25, 2020, 06:47 PM |
Cui Jingrong Jean | Director | Mar 24, 2020 | Sale | $41.95 | 7,000 | 293,655 | 817,083 | Mar 25, 2020, 06:47 PM |
Cui Jingrong Jean | Director | Mar 23, 2020 | Sale | $38.39 | 7,000 | 268,706 | 824,483 | Mar 25, 2020, 06:47 PM |
Cui Jingrong Jean | Director | Mar 11, 2020 | Sale | $41.20 | 18,500 | 762,202 | 846,183 | Mar 12, 2020, 08:40 PM |
Cui Jingrong Jean | Director | Mar 10, 2020 | Sale | $42.28 | 18,500 | 782,113 | 862,283 | Mar 12, 2020, 08:40 PM |
Cui Jingrong Jean | Director | Mar 12, 2020 | Sale | $36.08 | 7,000 | 252,528 | 829,783 | Mar 12, 2020, 08:40 PM |
Cui Jingrong Jean | Director | Feb 24, 2020 | Sale | $53.70 | 7,000 | 375,930 | 884,383 | Feb 26, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Feb 26, 2020 | Sale | $51.43 | 7,000 | 360,014 | 871,983 | Feb 26, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Feb 25, 2020 | Sale | $51.35 | 7,000 | 359,478 | 879,858 | Feb 26, 2020, 08:20 PM |
Cui Jingrong Jean | Director | Dec 30, 2019 | Option Exercise | $5.12 | 16,864 | 86,344 | 890,383 | Feb 26, 2020, 08:18 PM |
Cui Jingrong Jean | Director | Dec 27, 2019 | Option Exercise | $4.71 | 38,080 | 179,456 | 873,519 | Feb 26, 2020, 08:18 PM |
Cui Jingrong Jean | Director | Jun 27, 2019 | Option Exercise | $5.12 | 54,220 | 277,606 | 835,439 | Feb 26, 2020, 08:18 PM |
Cui Jingrong Jean | Director | Feb 13, 2020 | Sale | $61.84 | 11,500 | 711,137 | 792,519 | Feb 14, 2020, 04:22 PM |
Cui Jingrong Jean | Director | Feb 12, 2020 | Sale | $65.92 | 18,500 | 1,219,594 | 805,419 | Feb 12, 2020, 07:31 PM |
Cui Jingrong Jean | Director | Feb 11, 2020 | Sale | $63.23 | 18,500 | 1,169,667 | 815,469 | Feb 12, 2020, 07:31 PM |
Cui Jingrong Jean | Director | Feb 10, 2020 | Sale | $62.94 | 18,500 | 1,164,482 | 838,968 | Feb 12, 2020, 07:31 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 28, 2020 | Sale | $58.36 | 7,000 | 408,529 | 858,151 | Jan 29, 2020, 07:37 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 27, 2020 | Sale | $57.66 | 7,000 | 403,652 | 867,620 | Jan 29, 2020, 07:37 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 29, 2020 | Sale | $58.73 | 7,000 | 411,104 | 851,820 | Jan 29, 2020, 07:37 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 15, 2020 | Sale | $53.12 | 11,500 | 610,853 | 870,819 | Jan 17, 2020, 05:10 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 14, 2020 | Sale | $53.56 | 18,500 | 990,811 | 895,829 | Jan 14, 2020, 07:17 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 13, 2020 | Sale | $52.87 | 18,500 | 978,073 | 909,813 | Jan 14, 2020, 07:17 PM |
Cui Jingrong Jean | Chief Scientific Officer | Jan 10, 2020 | Sale | $57.68 | 18,500 | 1,067,161 | 935,919 | Jan 14, 2020, 07:17 PM |
Countouriotis Athena | President & CEO | Dec 10, 2019 | Option Exercise | $31.13 | 706 | 21,976 | 22,706 | Jan 08, 2020, 04:24 PM |
Baker Brian Lee | VP of Finance and Admin. | Dec 10, 2019 | Option Exercise | $31.13 | 216 | 6,723 | 3,016 | Jan 08, 2020, 04:12 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 20, 2019 | Sale | $63.40 | 11,500 | 729,150 | 946,319 | Dec 20, 2019, 06:29 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 19, 2019 | Sale | $61.09 | 18,500 | 1,130,257 | 964,819 | Dec 20, 2019, 06:29 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 18, 2019 | Sale | $59.20 | 18,500 | 1,095,170 | 980,989 | Dec 20, 2019, 06:29 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 13, 2019 | Sale | $55.75 | 11,500 | 641,169 | 1,019,119 | Dec 17, 2019, 09:09 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 17, 2019 | Sale | $61.32 | 18,500 | 1,134,374 | 999,619 | Dec 17, 2019, 09:09 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 16, 2019 | Sale | $58.35 | 11,500 | 671,077 | 1,014,119 | Dec 17, 2019, 09:09 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 12, 2019 | Sale | $54.11 | 11,500 | 622,291 | 1,037,219 | Dec 12, 2019, 07:54 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 11, 2019 | Sale | $52.94 | 11,500 | 608,787 | 1,040,291 | Dec 12, 2019, 07:54 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 10, 2019 | Sale | $54.58 | 11,500 | 627,631 | 1,058,019 | Dec 12, 2019, 07:54 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 05, 2019 | Sale | $51.95 | 56,110 | 2,914,936 | 1,157,939 | Dec 09, 2019, 08:44 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 09, 2019 | Sale | $55.32 | 11,500 | 636,229 | 1,069,219 | Dec 09, 2019, 08:44 PM |
Cui Jingrong Jean | Chief Scientific Officer | Dec 06, 2019 | Sale | $50.77 | 50,890 | 2,583,588 | 1,086,482 | Dec 09, 2019, 08:44 PM |
GLAXOSMITHKLINE PLC | Director | Sep 10, 2019 | Buy | $45.00 | 177,777 | 7,999,965 | 2,170,327 | Sep 12, 2019, 04:18 PM |
George Simeon | Director | Sep 10, 2019 | Buy | $45.00 | 177,777 | 7,999,965 | 2,170,327 | Sep 11, 2019, 06:42 PM |
Larson Yi | EVP & Chief Financial Officer | Sep 10, 2019 | Buy | $45.00 | 2,222 | 99,990 | 2,222 | Sep 11, 2019, 04:16 PM |
Countouriotis Athena | President & CEO | Sep 10, 2019 | Buy | $45.00 | 10,000 | 450,000 | 22,000 | Sep 11, 2019, 04:15 PM |
Cormorant Asset Management, LP | 10% Owner | May 14, 2019 | Option Exercise | $2.19 | 23,268 | 51,062 | 3,122,367 | May 16, 2019, 04:15 PM |
Cormorant Asset Management, LP | 10% Owner | Apr 22, 2019 | Buy | $18.00 | 400,000 | 7,200,000 | 3,099,099 | Apr 25, 2019, 04:08 PM |
GLAXOSMITHKLINE PLC | Director | Apr 22, 2019 | Buy | $18.00 | 325,000 | 5,850,000 | 1,992,550 | Apr 24, 2019, 07:28 PM |
ORBIMED ADVISORS LLC | Director | Apr 22, 2019 | Buy | $18.00 | 360,000 | 6,480,000 | 2,027,550 | Apr 24, 2019, 06:16 PM |
Lu Hongbo | Director | Apr 22, 2019 | Buy | $18.00 | 60,000 | 1,080,000 | 1,727,550 | Apr 24, 2019, 06:11 PM |
GORDON CARL L | Director | Apr 22, 2019 | Buy | $18.00 | 360,000 | 6,480,000 | 2,027,550 | Apr 24, 2019, 06:07 PM |
George Simeon | Director | Apr 22, 2019 | Buy | $18.00 | 325,000 | 5,850,000 | 1,992,550 | Apr 24, 2019, 06:04 PM |
Baker Brian Lee | VP of Finance and Admin. | Apr 22, 2019 | Buy | $18.00 | 2,800 | 50,400 | 2,800 | Apr 24, 2019, 06:00 PM |
Countouriotis Athena | President & CEO | Apr 22, 2019 | Buy | $18.00 | 12,000 | 216,000 | 12,000 | Apr 24, 2019, 05:55 PM |
Owner | Relationship | Date | Value($) |
George Simeon | Director | 08/17/2022 | 171,278,160 |
Alles Mark J | Director | 08/17/2022 | 152,000 |
TOMBESI PAOLO | EVP & Chief Financial Officer | 08/17/2022 | 2,263,128 |
Hirmand Mohammad | EVP and Chief Medical Officer | 08/17/2022 | 3,137,584 |
Countouriotis Athena | President & CEO | 08/17/2022 | 8,432,884 |
TOMBESI PAOLO | EVP & Chief Financial Officer | 07/27/2022 | 88,654 |
Reich Siegfried | EVP & Chief Scientific Officer | 02/09/2022 | 14,411 |
Partridge Andrew John | EVP & Chief Commercial Officer | 02/09/2022 | 8,022 |
North Annette | EVP & General Counsel | 02/09/2022 | 24,285 |
Hirmand Mohammad | EVP & Chief Medical Officer | 02/09/2022 | 24,285 |
Countouriotis Athena | President & CEO | 02/09/2022 | 107,847 |
North Annette | EVP, General Counsel & Secty. | 08/30/2021 | 170,000 |
North Annette | EVP, General Counsel & Secty. | 08/30/2021 | 800,000 |
Partridge Andrew John | EVP & Chief Commercial Officer | 07/14/2021 | 139,988 |
Alles Mark J | Director | 06/21/2021 | 162,680 |
Baker Brian Lee | SVP of Finance and Admin. | 03/23/2021 | 132,906 |
Baker Brian Lee | SVP of Finance and Admin. | 03/23/2021 | 2,862,082 |
North Annette | EVP, General Counsel & Secty. | 03/08/2021 | 340,000 |
North Annette | EVP, General Counsel & Secty. | 03/08/2021 | 2,195,939 |
Reich Siegfried | EVP & Chief Scientific Officer | 03/04/2021 | 1,823,004 |
Reich Siegfried | EVP & Chief Scientific Officer | 03/04/2021 | 3,734,075 |
Countouriotis Athena | President & CEO | 02/11/2021 | 28,614 |
Countouriotis Athena | President & CEO | 02/10/2021 | 81,254 |
Countouriotis Athena | President & CEO | 02/09/2021 | 82,131 |
Countouriotis Athena | President & CEO | 02/11/2021 | 1,228,446 |
Countouriotis Athena | President & CEO | 02/10/2021 | 3,461,116 |
Countouriotis Athena | President & CEO | 02/09/2021 | 3,559,475 |
North Annette | EVP, General Counsel & Secty. | 02/02/2021 | 153,272 |
North Annette | EVP, General Counsel & Secty. | 02/01/2021 | 271,728 |
North Annette | EVP, General Counsel & Secty. | 02/02/2021 | 1,170,989 |
North Annette | EVP, General Counsel & Secty. | 02/01/2021 | 1,976,374 |
Larson Yi | EVP & Chief Financial Officer | 02/01/2021 | 848,379 |
Larson Yi | EVP & Chief Financial Officer | 02/02/2021 | 772,521 |
Larson Yi | EVP & Chief Financial Officer | 02/01/2021 | 1,941,105 |
Larson Yi | EVP & Chief Financial Officer | 02/02/2021 | 1,860,813 |
Baker Brian Lee | SVP of Finance and Admin. | 01/07/2021 | 132,918 |
Baker Brian Lee | SVP of Finance and Admin. | 01/07/2021 | 3,819,090 |
Hirmand Mohammad | EVP and Chief Medical Officer | 01/04/2021 | 478,723 |
Hirmand Mohammad | EVP and Chief Medical Officer | 01/05/2021 | 68,577 |
Hirmand Mohammad | EVP and Chief Medical Officer | 01/05/2021 | 150,360 |
Hirmand Mohammad | EVP and Chief Medical Officer | 01/04/2021 | 1,090,046 |
Cui Jingrong Jean | Director | 06/09/2020 | 625,194 |
Cui Jingrong Jean | Director | 06/08/2020 | 1,173,888 |
Cui Jingrong Jean | Director | 06/05/2020 | 1,187,868 |
Cui Jingrong Jean | Director | 06/04/2020 | 1,198,891 |
George Simeon | Director | 05/21/2020 | 4,999,980 |
Countouriotis Athena | President & CEO | 05/21/2020 | 249,960 |
GLAXOSMITHKLINE PLC | Director | 05/21/2020 | 4,999,980 |
Cui Jingrong Jean | Director | 05/19/2020 | 404,108 |
Cui Jingrong Jean | Director | 05/21/2020 | 417,550 |
Cui Jingrong Jean | Director | 05/20/2020 | 421,045 |
Cui Jingrong Jean | Director | 05/08/2020 | 619,351 |
Cui Jingrong Jean | Director | 05/07/2020 | 977,886 |
Cui Jingrong Jean | Director | 05/06/2020 | 979,323 |
Cui Jingrong Jean | Director | 05/05/2020 | 999,426 |
Cui Jingrong Jean | Director | 04/23/2020 | 363,408 |
Cui Jingrong Jean | Director | 04/22/2020 | 362,481 |
Cui Jingrong Jean | Director | 04/24/2020 | 357,090 |
Cui Jingrong Jean | Director | 04/13/2020 | 35,438 |
Cui Jingrong Jean | Director | 04/09/2020 | 545,648 |
Cui Jingrong Jean | Director | 04/06/2020 | 804,874 |
Cui Jingrong Jean | Director | 04/08/2020 | 855,604 |
Cui Jingrong Jean | Director | 04/07/2020 | 829,998 |
Cui Jingrong Jean | Director | 03/26/2020 | 529,372 |
Cui Jingrong Jean | Director | 03/25/2020 | 808,090 |
Cui Jingrong Jean | Director | 03/24/2020 | 293,655 |
Cui Jingrong Jean | Director | 03/23/2020 | 268,706 |
Cui Jingrong Jean | Director | 03/11/2020 | 762,202 |
Cui Jingrong Jean | Director | 03/10/2020 | 782,113 |
Cui Jingrong Jean | Director | 03/12/2020 | 252,528 |
Cui Jingrong Jean | Director | 02/24/2020 | 375,930 |
Cui Jingrong Jean | Director | 02/26/2020 | 360,014 |
Cui Jingrong Jean | Director | 02/25/2020 | 359,478 |
Cui Jingrong Jean | Director | 12/30/2019 | 86,344 |
Cui Jingrong Jean | Director | 12/27/2019 | 179,456 |
Cui Jingrong Jean | Director | 06/27/2019 | 277,606 |
Cui Jingrong Jean | Director | 02/13/2020 | 711,137 |
Cui Jingrong Jean | Director | 02/12/2020 | 1,219,594 |
Cui Jingrong Jean | Director | 02/11/2020 | 1,169,667 |
Cui Jingrong Jean | Director | 02/10/2020 | 1,164,482 |
Cui Jingrong Jean | Chief Scientific Officer | 01/28/2020 | 408,529 |
Cui Jingrong Jean | Chief Scientific Officer | 01/27/2020 | 403,652 |
Cui Jingrong Jean | Chief Scientific Officer | 01/29/2020 | 411,104 |
Cui Jingrong Jean | Chief Scientific Officer | 01/15/2020 | 610,853 |
Cui Jingrong Jean | Chief Scientific Officer | 01/14/2020 | 990,811 |
Cui Jingrong Jean | Chief Scientific Officer | 01/13/2020 | 978,073 |
Cui Jingrong Jean | Chief Scientific Officer | 01/10/2020 | 1,067,161 |
Countouriotis Athena | President & CEO | 12/10/2019 | 21,976 |
Baker Brian Lee | VP of Finance and Admin. | 12/10/2019 | 6,723 |
Cui Jingrong Jean | Chief Scientific Officer | 12/20/2019 | 729,150 |
Cui Jingrong Jean | Chief Scientific Officer | 12/19/2019 | 1,130,257 |
Cui Jingrong Jean | Chief Scientific Officer | 12/18/2019 | 1,095,170 |
Cui Jingrong Jean | Chief Scientific Officer | 12/13/2019 | 641,169 |
Cui Jingrong Jean | Chief Scientific Officer | 12/17/2019 | 1,134,374 |
Cui Jingrong Jean | Chief Scientific Officer | 12/16/2019 | 671,077 |
Cui Jingrong Jean | Chief Scientific Officer | 12/12/2019 | 622,291 |
Cui Jingrong Jean | Chief Scientific Officer | 12/11/2019 | 608,787 |
Cui Jingrong Jean | Chief Scientific Officer | 12/10/2019 | 627,631 |
Cui Jingrong Jean | Chief Scientific Officer | 12/05/2019 | 2,914,936 |
Cui Jingrong Jean | Chief Scientific Officer | 12/09/2019 | 636,229 |
Cui Jingrong Jean | Chief Scientific Officer | 12/06/2019 | 2,583,588 |
GLAXOSMITHKLINE PLC | Director | 09/10/2019 | 7,999,965 |
George Simeon | Director | 09/10/2019 | 7,999,965 |
Larson Yi | EVP & Chief Financial Officer | 09/10/2019 | 99,990 |
Countouriotis Athena | President & CEO | 09/10/2019 | 450,000 |
Cormorant Asset Management, LP | 10% Owner | 05/14/2019 | 51,062 |
Cormorant Asset Management, LP | 10% Owner | 04/22/2019 | 7,200,000 |
GLAXOSMITHKLINE PLC | Director | 04/22/2019 | 5,850,000 |
ORBIMED ADVISORS LLC | Director | 04/22/2019 | 6,480,000 |
Lu Hongbo | Director | 04/22/2019 | 1,080,000 |
GORDON CARL L | Director | 04/22/2019 | 6,480,000 |
George Simeon | Director | 04/22/2019 | 5,850,000 |
Baker Brian Lee | VP of Finance and Admin. | 04/22/2019 | 50,400 |
Countouriotis Athena | President & CEO | 04/22/2019 | 216,000 |